Risk factors for hospital acquisition of trimethoprim-sulfamethoxazole resistant Stenotrophomonas maltophilia in adults: A matched case-control study

被引:13
作者
Wang, Ching-Hsun [1 ]
Lin, Jung-Chung [1 ]
Chang, Feng-Yee [1 ]
Yu, Ching-Mei [2 ]
Lin, Wei-San [3 ]
Yeh, Kuo-Ming [1 ]
机构
[1] Triserv Gen Hosp, Dept Internal Med, Div Infect Dis & Trop Med, Natl Def Med Ctr, 325,Sect 2,Cheng Kung Rd,Neihu 114, Taipei, Taiwan
[2] Triserv Gen Hosp, Natl Def Med Ctr, Dept Pathol, Taipei, Taiwan
[3] Taipei Med Univ, Coll Med Sci & Technol, Grad Inst Biomed Informat, Taipei, Taiwan
关键词
Risk; Resistance; Stenotrophomonas maltophilia; Trimethoprim-sulfamethoxazole; URINARY-TRACT-INFECTION; OPPORTUNISTIC PATHOGEN; ANTIBIOTIC-RESISTANCE; TAIWAN; COTRIMOXAZOLE; SURVEILLANCE; MULTICENTER; BACTEREMIA; EMERGENCE; FEATURES;
D O I
10.1016/j.jmii.2016.12.007
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background/Purpose: The emergence of trimethoprim-sulfamethoxazole resistant Stenotrophomonas maltophilia (TSRSM) represents a serious threat to patients. The aim of current study was to identify risk factors associated with hospital-acquired TSRSM occurrence in adult inpatients. Methods: We conducted a matched case-control study in Tri-Service General Hospital, Taipei, Taiwan. From January 2014 through June 2015, case patients with TSRSM and control patients with trimethoprim-sulfamethoxazole susceptible S. maltophilia (TSSSM) during hospitalization were identified. Control patients were matched with TSRSM cases for age (within five years), sex, and site of isolation at a ratio of 1: 1. Results: A total of 266 patients were included in our study (133 cases and 133 matched controls). Bivariable analysis showed that previous exposure to fluoroquinolone [odds ratio (OR), 2.693; 95% confidence interval (CI, 1.492-5.884; p = 0.002)], length of intensive care unit stay (OR, 1.015 per day; 95% CI, 1.001-1.030; p = 0.041), and length of hospital stay (OR, 1.012 per day; 95% CI, 1.002-1.023; p = 0.018) prior to S. maltophilia isolation were associated with TSRSM occurrence. A multivariable analysis showed that previous exposure to fluoroquinolone (OR, 3.158; 95% CI, 1.551-6.430; p= 0.002) was an independent risk factor for TSRSM occurrence after adjustment. Conclusion: Previous fluoroquinolone use was an independent risk factor for hospital-acquired TSRSM occurrence in adult inpatients, suggesting that judicious administration of fluoroquinolone may be important for limiting TSRSM occurrence. Copyright (C) 2017, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC.
引用
收藏
页码:646 / 652
页数:7
相关论文
共 31 条
[1]  
Abbott IJ, 2011, EXPERT REV ANTI-INFE, V9, P471, DOI [10.1586/ERI.11.24, 10.1586/eri.11.24]
[2]   Risk factors for infections with multidrug-resistant Stenotrophomonas maltophilia in patients with cancer [J].
Ansari, Shoaib R. ;
Hanna, Hend ;
Hachem, Ray ;
Jiang, Ying ;
Rolston, Kenneth ;
Raad, Issam .
CANCER, 2007, 109 (12) :2615-2622
[3]   The Efflux Pump SmeDEF Contributes to Trimethoprim-Sulfamethoxazole Resistance in Stenotrophomonas maltophilia [J].
Blanca Sanchez, Maria ;
Luis Martinez, Jose .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (07) :4347-4348
[4]   New strategies against Stenotrophomonas maltophilia: a serious worldwide intrinsically drug-resistant opportunistic pathogen [J].
Brooke, Joanna S. .
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2014, 12 (01) :1-4
[5]   Stenotrophomonas maltophilia: an Emerging Global Opportunistic Pathogen [J].
Brooke, Joanna S. .
CLINICAL MICROBIOLOGY REVIEWS, 2012, 25 (01) :2-41
[6]   Increased incidence of class 1 integrons in trimethoprim/sulfamethoxazole-resistant clinical isolates of Stenotrophomonas maltophilia [J].
Chang, Lin-Li ;
Lin, Hui-Hui ;
Chang, Chung-Yu ;
Lu, Po-Liang .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2007, 59 (05) :1038-1039
[7]  
Chang SC, 2001, J FORMOS MED ASSOC, V100, P155
[8]   Update on infections caused by Stenotrophomonas maltophilia with particular attention to resistance mechanisms and therapeutic options [J].
Chang, Ya-Ting ;
Lin, Chun-Yu ;
Chen, Yen-Hsu ;
Hsueh, Po-Ren .
FRONTIERS IN MICROBIOLOGY, 2015, 6
[9]   A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION [J].
CHARLSON, ME ;
POMPEI, P ;
ALES, KL ;
MACKENZIE, CR .
JOURNAL OF CHRONIC DISEASES, 1987, 40 (05) :373-383
[10]  
Clinical and Laboratory Standards Institute, M100S24 CLSI S